Gilead Sciences continues battling with insurers over hep C reimbursement
Company's patient-assistance program becomes a weapon; meanwhile cure rates as high as 98.4% are being claimed
ACCME sees more criticism of pharma-sponsored continuing medication education
Labor unions want an end to pharma-sponsored CME
Ingestible sensor offers promise for medication adherence
Novartis, Otsuka will pilot projects with Proteus Digital Health
Specialized cold chain packaging addresses patient, blood-transportation concerns
Sofrigam promotes its Igloo kit for pharmacy-to-home; Sonoco, a new reusable container
DeltaTrak and Modality Solutions partner to address cold-chain technical issues
Risk assessment/mitigation is a key unmet need
FusionOps brings enhanced supply chain visibility to pharma with new analytics capabilities
Cloud-based system is said to take only days to set up and run
Shifts in the retail pharmacy landscape
Latest SK&A pharmacy data outlines retail channel
Streck whistleblower case is settled for $55.5 million by AstraZeneca and others
Litigation points to the complexity of 'fair market value' calculations in manufacturer-wholesaler agreements
CMS publishes near-complete Open Payments data for 2014
What do 9.4 million lunches, breakfasts and funded coffee breaks do for the healthcare professions?
Now, the civil litigation over the infamous Eli Lilly Enfield robbery
Florida court case could have implications for how warehouse security is maintained
Vial label has 10 detachable parts for documentation, medication safety tracking
Schreiner MediPharm develops the 10-part label as an extension of its Pharm-Comb series
Manufacturers can support the ICD-10 transition
Healthcare's conversion to a new coding system can affect drug prescribing. Here's what you need to know
Building a cold-chain data network
Technology and regulations drive shippers toward more data collection and reporting
Biotech manufacturing capacity is expanding in North America
Viral products, IVIG and stem cell production is coming online
Novartis: No. 1 pharma company in the world in 2020, says Evaluate Pharma
Market-data firm estimates 2020 global drug sales at $987 billion
2015 PDMA Sharing Conference
A silver anniversary with golden opportunities
PwC projects a 6.5% growth in medical trend for commercial payers in 2016
Medical cost growth rate has been nearly halved since 2007, but remains above general inflation rates
The Phase III pricing experiment
Moving the needle on diabetes
While the biopharma industry continues to develop better treatment options, there is a stronger focus on more intensive patient engagement
Product launch--the 21st-century way
New IT tools are propelling a more focused approach to product launch
Get better at managing clinical trial financials
Control of costs and accounting during clinical trials is a well-known challenge to sponsors. Tools are available
Patient-centric support for specialty drug therapy--a new model to address the needs of a changing patient population
FDA gives pharmacies more DSCSA compliance time
But will a postponement to Nov. 1 make a difference?
A Conversation with Gary McWalters, TGaS Advisors
Forecasting for the Pharmaceutical Industry
The second edition of an essential business planner's library
Does healthcare benefit from a unified approach to item-level serialization and UDI?
"If we had asked them, they would have asked for faster horses." ~ Henry Ford
Obamacare's vindication will likely add momentum to insurance-giant mergers
Could PBMs be the big loser in how US healthcare is ultimately reshaped?
Pharmacists seek a delay in implementing drug traceabiity requirements
July 1 compliance deadline is looming large; half of surveyed pharmacies are unaware of implementation services
Novartis: No. 1 pharma company in the world now and in 2020, says Evaluate Pharma
Market-data firm estimates overall 2020 global drug sales at $987 billion
More healthcare-distribution capacity in Europe for UPS Healthcare Logistics
New distribution center in Netherlands creates 41,000-pallet capacity
